Company InformationExecutive Team
Directors
Representative Director, Chairman and President, Group Chief Executive Officer and Group Chief Operating Officer
Mitsuo Sawai
- Date of birth:
September 28, 1956
- April 1982:
Joined Kyowa Hakko Kogyo Co., Ltd. (currently Kyowa Kirin Co., Ltd.)
- January 1989:
Joined Sawai Pharmaceutical Co., Ltd.
- June 2000:
Director, Deputy Vice President of Sales Division, and General Manager of Sales Planning Department
- June 2002:
Managing Director, Deputy Vice President of Sales Division, and General Manager of Sales Planning Department
- June 2005:
Senior Managing Director, Vice President of Sales Division
- June 2008:
Representative Director, President
- June 2020:
Representative Director, Chairman (incumbent)
- April 2021:
Representative Director, Chairman of the Company
- June 2023:
Representative Director, Chairman and President of the Company (incumbent)
Director, Senior Managing Executive Officer, and Group Chief Research & Development Officer
Shoji Yokota
- Date of birth:
July 22, 1957
- April 1982:
Joined Yamanouchi Pharmaceutical Co., Ltd. (currently Astellas Pharma Inc.)
- September 2016:
Joined Sawai Pharmaceutical Co., Ltd.
- June 2017:
Corporate Officer, and Deputy Vice President of Research & Development Division, and Director of Analytical Chemistry Department
- June 2019:
Senior Executive Officer, and Vice President of Research & Development Division
- April 2021:
Director, Senior Executive Officer, and Vice President of Research & Development Division
Managing Executive Officer of the Company - June 2023:
Director, Senior Managing Executive Officer of the Company (incumbent)
Director, Senior Managing Executive Officer of Sawai Pharmaceutical Co., Ltd. (incumbent)
External Director
Masatoshi Ohara
- Date of birth:
April 25, 1951
- April 1979:
Registered as a lawyer at Osaka Bar Association
Joined Kikkawa Sogo Law Offices (currently Kikkawa Law Offices) - February 1987:
Attorney registered in the State of New York, the U.S.
- January 1988:
Partner of Kikkawa Law Offices (incumbent)
- April 2004:
Member of the Board of Directors for the Kinki Federation of Bar Associations
- April 2017:
The President of Osaka Bar Association, the Vice President of Japan Federation of Bar Associations
- June 2019:
Director of Sawai Pharmaceutical Co., Ltd.
- April 2021:
Director of the Company (incumbent)
- September 2022:
External Auditor of Shibuya Corporation (incumbent)
- June 2023:
External Director of Atsugi Co., Ltd. (incumbent)
External Director
Nawomi Todo
- Date of birth:
September 17, 1959
- June 1984:
Obtained medical license
- July 1984:
Staff Doctor at Osaka University Hospital
- July 1987:
Staff Doctor at Osaka Police Hospital, Association of Osaka Police Foundation
- July 1990:
Staff Doctor at Nissay Hospital (currently Nippon Life Hospital)
- January 2002:
Staff Doctor at Osaka-tetsusyou Health Insurance Society (incumbent)
- January 2007:
Obtained Certified Occupational Physician Qualification of Japan Medical Association
- June 2015:
Director of Sawai Pharmaceutical Co., Ltd.
- April 2021:
Director of the Company (incumbent)
External Director
Masayuki Mitsuka
- Date of birth:
October 30, 1954
- April 1982:
Joined Mitsubishi Chemical Industries (currently Mitsubishi Chemical Corporation)
- June 2009:
Board Director, Executive Officer, General Manager of Global Product Strategy Department of Mitsubishi Tanabe Pharma Corporation
- April 2012:
Board Director, Managing Executive Officer, Division Manager of Development Division
- April 2014:
Representative Director, Senior Managing Executive Officer
- June 2014:
President & Representative Director, Chief Executive Officer
- April 2020:
Board Director
- June 2020:
Advisor
- June 2023:
Director of the Company (incumbent)
Audit & Supervisory Board Members
Full-time Audit & Supervisory Board Member
Tadao Tsubokura
-
July 2008:
Joined Sawai Pharmaceutical Co., Ltd.; General Manager, Controller Department
-
April 2012:
General Manager, General Affairs Department
-
June 2018:
Full-time Audit & Supervisory Board Member
-
April 2021:
Full-time Audit & Supervisory Board Member of the Company and Audit & Supervisory Board Member of Sawai Pharmaceutical (incumbent)
External Audit & Supervisory Board Member
Takanobu Tomohiro
-
April 1991:
Registered as an attorney, joined Kogoshi Takizawa Law Office (currently, Kobe-Kaito Law Office)
-
April 1994:
Partner of Kobe-Kaito Law Office (incumbent)
-
June 2016:
Audit & Supervisory Board Member of Sawai Pharmaceutical
-
April 2020:
President, Hyogo-ken Bar Association
-
April 2021:
External Audit & Supervisory Board Member of the Company (incumbent)
-
June 2023:
External Director of Kyokuto Kaihatsu Kogyo Co., Ltd. (incumbent)
External Audit & Supervisory Board Member
Junichi Hirano
-
July 2013:
Enterprise Examination Department, Osaka Regional Taxation Bureau
-
July 2014:
District Director, Higashi Yodogawa Tax Office
-
July 2015:
District Director, Himeji Tax Office
-
August 2016:
Established a certified tax accountant office, and assumed the position of president (incumbent)
-
June 2017:
Audit & Supervisory Board Member of Sawai Pharmaceutical
-
June 2019:
External auditor of MIWA CORPORATION (incumbent)
-
April 2021:
External Audit & Supervisory Board Member of the Company (incumbent)
Additional Officers
Motohiko Kimura
Senior Managing Executive Officer
Toshiya Hasuo
Group Chief Production Officer
Nobuko Sugimoto
Group Chief Intellectual Property Officer
Toru Terashima
Senior Executive Officer
Seiji Nishimura
Group Chief Marketing Officer
Toshiomi Nakate
Group Chief Quality & Safety Officer
Taku Nakaoka
Group Chief Corporate Planning Officer, Group Chief Financial Officer, Group Chief Compliance Officer and Group Chief Sustainability Officer
Toyohiro Sawada
Group Chief Product Strategy Officer and Group Deputy Chief Research & Development Officer
Koji Takeda
Group Chief Digital Transformation Officer